FDA issues warning on use of azithromycin

03/13/2013 | Los Angeles Times (tiered subscription model) · Reuters

The FDA issued a warning that the antibiotic azithromycin, marketed as Zithromax or Zmax, could cause potentially fatal irregular heart rhythm in some patients. The agency said at-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia.

View Full Article in:

Los Angeles Times (tiered subscription model) · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN